ATH 11.1% 0.4¢ alterity therapeutics limited

Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-7

  1. 18 Posts.
    lightbulb Created with Sketch. 8
    pivalde, do we know the length of the long term toxicology study in dogs that caused the clinical hold? I imagine it would have been at least the length of a potential Ph3 trial? 1year+? Also, Has Queensland provided the dose they used in the preclinical study? I would love to know the dose equivalent in humans that would be efficacious in the AMR setting. at/above/below 250mg?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $10.55K 2.255M

Buyers (Bids)

No. Vol. Price($)
64 78009948 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28507238 24
View Market Depth
Last trade - 15.09pm 25/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.